SARS‐CoV‐2 variants and vulnerability at the global level
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …
Evolution of SARS-CoV-2 variants: implications on immune escape, vaccination, therapeutic and diagnostic strategies
NZ Zabidi, HL Liew, IA Farouk, A Puniyamurti, AJW Yip… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …
Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates
Coronavirus disease 2019 (COVID-19) was first identified in respiratory samples and was
found to commonly cause cough and pneumonia. However, non-respiratory symptoms …
found to commonly cause cough and pneumonia. However, non-respiratory symptoms …
Some common deleterious mutations are shared in SARS-CoV-2 genomes from deceased COVID-19 patients across continents
The identification of deleterious mutations in different variants of SARS-CoV-2 and their
roles in the morbidity of COVID-19 patients has yet to be thoroughly investigated. To unravel …
roles in the morbidity of COVID-19 patients has yet to be thoroughly investigated. To unravel …
Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB. 1.16
The World Health Organisation (WHO) estimated 780 million severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections and approximately 6.9 million deaths …
syndrome coronavirus 2 (SARS-CoV-2) infections and approximately 6.9 million deaths …
[HTML][HTML] Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of …
Objectives We used whole-genome sequencing of SARS-CoV-2 to identify variants
circulating in the Democratic Republic of the Congo and obtain molecular information useful …
circulating in the Democratic Republic of the Congo and obtain molecular information useful …
Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future
Z Zeng, X Geng, X Wen, Y Chen, Y Zhu… - Frontiers in …, 2023 - frontiersin.org
Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
its resultant pneumonia in December 2019, the cumulative number of infected people …
its resultant pneumonia in December 2019, the cumulative number of infected people …
Development of next generation vaccines against SARS-CoV-2 and variants of concern
SARS-CoV-2 has caused the COVID-19 pandemic, with over 673 million infections and 6.85
million deaths globally. Novel mRNA and viral-vectored vaccines were developed and …
million deaths globally. Novel mRNA and viral-vectored vaccines were developed and …
Prerequisite for COVID-19 prediction: a review on factors affecting the infection rate
Since the year 2020, coronavirus disease 2019 (COVID-19) has emerged as the dominant
topic of discussion in the public and research domains. Intensive research has been carried …
topic of discussion in the public and research domains. Intensive research has been carried …